At a glance

ClinicalIndex Comparison Record

N/ACompleted· 48 enrolled

Drug / intervention

LIMFA Therapy®device

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03503760

NCT03503760N/ACompleted

Compare CT.gov

Efficacy of Extremely Low Magnetic Field (ELF) in Fibromyalgic Patients: Effect on Symptoms Severity, Sleep and Quality of Life.

Azienda Ospedaliera Universitaria Integrata Verona·interventional·Posted Apr 20, 2018·Updated Apr 20, 2018

In Brief

A clinical study evaluating LIMFA Therapy® for Fibromyalgia. Completed, enrolled 48 participants.

Detailed Summary

This is a randomized double-blind crossover study. The investigators applied ELF with a device named "LIMFA Therapy®" to 48 fibromyalgic patients, assigned in two groups (true-sham and sham-true). Fibromyalgia severity was assessed with the Fibromyalgia Impact Questionnaire (FIQ), quality of sleep with the Pittsburgh Sleep Quality Index (PSQI) questionnaire and global quality of life with Short Form-12 of Physical and Mental Health Summary (SF-12) questionnaire.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsFibromyalgia

Countries--

Collaborators--

Timeline

N/ACompletedFinished

2017201820192020202120222023202420252026

Enrollment StartJul 2016

Primary CompletionJul 2017

First PostedApr 2018

TodayJul 2026

First PostedApr 20, 2018

Enrollment StartJul 1, 2016

Primary CompletionJul 1, 2017

TodayJul 2, 2026

Enrollment to primary: 1 yearPosted 8.2 years ago

Interventions

LIMFA Therapy®device

It applies a packages of magneto-electric field sequences having variable geometry, with frequencies and intensities that vary in a range of 0-80 Hertz and 0-100 microTesla, respectively.